Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Steff, A.-M.
Right arrow Articles by Gosselin, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steff, A.-M.
Right arrow Articles by Gosselin, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 19, No. 1, 172-178, January 2004
© 2004 European Society of Human Reproduction and Embryology

Concentration of soluble intercellular adhesion molecule-1 in serum samples from patients with endometriosis collected during the luteal phase of the menstrual cycle

A.-M. Steff, D. Gagné, M. Pagé, P. Hugo and D. Gosselin1

MetrioGene BioSciences, Inc. (a subsidiary of Procrea BioSciences, Inc.), 6100 Royalmount Avenue, Montreal (Quebec) H4P 2R2, Canada

1 To whom correspondence should be addressed. e-mail: dgosselin{at}metriogene.com

BACKGROUND: Soluble intercellular adhesion molecule-1 (sICAM-1), released by endometriotic lesions, is involved in the regulation of cytotoxic processes. Altered levels of sICAM-1 in the circulation could parallel its deregulation in the peritoneal cavity. We therefore investigated whether sICAM-1 could represent a serum marker for endometriosis. METHODS: sICAM-1 levels were measured by enzyme-linked immunosorbent assay in serum samples from 176 subjects with surgically confirmed endometriosis (134 patients with stage I–II and 42 patients with stage III–IV) and 198 controls with no surgical evidence of the disease. All serum samples were collected during the luteal phase of the menstrual cycle. Detailed information about demographics, symptoms and clinical profile were collected. RESULTS: Mean levels of sICAM-1 appeared significantly reduced in patients with stage III–IV endometriosis in a crude comparison of means. However, when means were adjusted for potential confounders such as the pre-operative indication or fertility status, no significant difference between cases with stage III–IV disease and controls was observed. CONCLUSIONS: Serum levels of sICAM-1 during the luteal phase of the cycle are not able to discriminate women suffering from endometriosis from controls when confounders are taken into account. These results underline the importance of careful identification of confounders, based on patients’ demographic and clinical data in studies aiming at discovering diagnostic markers for endometriosis.

Key words: clinical profile/confounders/diagnostic/inflammation/serum markers


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
F. F. Verit, O. Erel, and N. Celik
Serum paraoxonase-1 activity in women with endometriosis and its relationship with the stage of the disease
Hum. Reprod., January 1, 2008; 23(1): 100 - 104.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Print, R. Valtola, A. Evans, K. Lessan, S. Malik, and S. Smith
Soluble factors from human endometrium promote angiogenesis and regulate the endothelial cell transcriptome
Hum. Reprod., October 1, 2004; 19(10): 2356 - 2366.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.